These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2093418)

  • 1. A review of the EEG effects of the combination of almitrine and raubasine in animals and humans.
    Sebban C; Tesolin B; Schatz C; Malbezin M; Guez D
    Clin Neuropharmacol; 1990; 13 Suppl 3():S50-8. PubMed ID: 2093418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of almitrine and raubasine, singly and in combination, on electroencephalographic activity in young and old rats.
    Sebban C; Tesolin B; Coulomb B; Berthaux P
    Exp Gerontol; 1989; 24(1):11-24. PubMed ID: 2707311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative electroencephalography in aging brain and cerebrovascular disease: the effects of almitrine-raubasine.
    Sebban C
    Eur Neurol; 1995; 35 Suppl 1():37-42. PubMed ID: 8529728
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of the effects of almitrine, raubasine and 5023 SE on arterial oxygen desaturation during exercise].
    Sebban C; Berthaux P
    Presse Med; 1983 Mar; 12(13):847-8. PubMed ID: 6220334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Almitrine-raubasine and cognitive impairment in the elderly: results of a 6-month controlled multicenter study.
    Poitrenaud J; Piette F; Malbezin M; Sebban C; Guez D
    Clin Neuropharmacol; 1990; 13 Suppl 3():S100-8. PubMed ID: 2093414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of almitrine-raubasine in cognitive disorders of aging: a double-blind, placebo-controlled, clinical and psychometric study.
    Carbonin PU; Greco A; Pisanti P; Gemma A; Cattelin F
    Clin Neuropharmacol; 1990; 13 Suppl 3():S92-9. PubMed ID: 2093422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, placebo-controlled quantitative EEG and psychometric studies in elderlies on vigilance-promoting effects of an almitrine/raubasine combination (Duxil).
    Saletu B; Grünberger J; Linzmayer L; Anderer P
    Arch Gerontol Geriatr; 1988 Jun; 7(2):93-110. PubMed ID: 3415398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in understanding the pathophysiology of cerebral ischemia: the almitrine-raubasine approach.
    Bentué-Ferrer D; Decombe R; Reymann JM; Schatz C; Allain H
    Clin Neuropharmacol; 1990; 13 Suppl 3():S9-25. PubMed ID: 2093421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects and safety of almitrine-raubasine in age-associated cognitive decline.
    Guez D
    Clin Neuropharmacol; 1990; 13 Suppl 3():S109-16. PubMed ID: 2093415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurologic and histologic evaluation of almitrine+raubasine (Duxil) in middle cerebral artery occlusion in cats.
    Chan P; Li Y; Zheng Z; Hu P; Sarbach SD; Guez D
    Eur J Pharmacol; 1993 Feb; 231(2):175-82. PubMed ID: 8453973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychometric evaluation of the effects of an almitrine-raubasine combination in the intellectual deterioration of aged subjects. A double-blind controlled trial versus placebo].
    Rapisarda V; Azzaro E; Fichera G
    Presse Med; 1987 Jun; 16(23):1163-6. PubMed ID: 2885827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memory disorders in 8,037 elderly patients with age-associated memory impairment: multicenter trial with a 6-month follow-up under almitrine-raubasine.
    Poitrenaud J; Laurent B; Sebban C
    Eur Neurol; 1995; 35 Suppl 1():43-6. PubMed ID: 8529729
    [No Abstract]   [Full Text] [Related]  

  • 13. [Quantified electroencephalogram: value in the evaluation of therapy of cerebral aging].
    Sebban C; Tesolin B; Guez D
    Presse Med; 1987 Jun; 16(23):1154-8. PubMed ID: 2885826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the therapeutic activity of a combination of almitrine and raubasine on functional rehabilitation following ischaemic stroke.
    Li S; Long J; Ma Z; Xu Z; Li J; Zhang Z
    Curr Med Res Opin; 2004 Mar; 20(3):409-15. PubMed ID: 15025850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability-indicating methods for the determination of a mixture of almitrine and raubasine by derivative spectrophotometry.
    El-Sayed MA
    Drug Test Anal; 2009 Jun; 1(6):279-85. PubMed ID: 20355207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curative effect of an almitrine-raubasine combination in the postischemic syndrome following transient cerebral ischemia in dogs.
    Cahn R; Cahn J
    Pharmacology; 1988; 36(3):156-65. PubMed ID: 3368502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of postischemic hypoxia and cerebral protection: implications of the almitrine and raubasine combination.
    Chan P
    Eur Neurol; 1995; 35 Suppl 1():23-7. PubMed ID: 8529726
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of almitrine/raubasine on cerebral metabolism in the elderly].
    Allain H; Bentué-Ferrer D
    Presse Med; 2002 Mar; 31(12):562-4. PubMed ID: 11984975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial fibrillary acidic protein expression after transient brain ischemia: evidence for a pharmacological modulation by almitrine-raubasine.
    Pujol JF; Ginovart N; Debure L; Rousset C; Weissmann D
    Eur Neurol; 1995; 35 Suppl 1():12-6. PubMed ID: 8529723
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic and circulatory evaluation of cerebral ischemic accident in humans by positron emission tomography: a pilot study with almitrine-raubasine.
    Depresseux JC; Franck G; Van Cauwenberge H; Cattelin F
    Clin Neuropharmacol; 1990; 13 Suppl 3():S40-9. PubMed ID: 2093417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.